Healthcare

Is Optima Health Strengthening Its FTSE 100 Live Position Through St...
May 06, 2025 09:30 AM BST | By Team Kalkine MediaHighlights,Optima Health PLC acquires Care first to expand its mental health services operations.,The move aligns with Optima’s long-term strategic gr...

How Is Itaconix Managing Tariff Impacts in the Detergent Polymers Ma...
May 06, 2025 07:30 AM BST | By Team Kalkine MediaHighlights,Itaconix reports strong detergent polymer demand early in the year amid changing global trade conditions.,Tariff changes have marginally af...

Can Genflow Biosciences Drive Innovation in the Biotech Sector Amid...
May 06, 2025 07:30 AM BST | By Team Kalkine MediaHighlights,Genflow Biosciences (GENF) received regulatory clearance to start direct clinical trials with MASH patients.,Research expanded into Werner...

Is Nuformix’s Inhaled Therapy Advancing Amid FTSE 350 Innovation Tre...
May 02, 2025 01:30 PM BST | By Team Kalkine MediaHighlights,Nuformix PLC posted widened losses and reduced cash reserves, while raising new funds through share subscriptions.,Discussions are ongoing...

What is the Latest Development from IQ-AI Ltd in Medical Imaging?
May 02, 2025 11:30 AM BST | By Team Kalkine MediaHighlights,IQ-AI Ltd (LSE:IQAI) is advancing in the medical imaging sector with a breakthrough therapy for glioblastoma.,The company’s subsidiary, Ima...

Is Totally PLC's Financial Stability in Question Amid Profit Revisio...
May 01, 2025 12:31 PM BST | By Team Kalkine MediaHighlights,Totally PLC reported a revised EBITDA outlook for the full year, citing lower margins and a phased contract completion.,The company's Chief...

Could GSK’s FTSE 100 and All-Share Status Gain from Nucala Trial Bre...
May 01, 2025 09:25 AM BST | By Team Kalkine MediaCould GSK’s FTSE 100 and All-Share Status Gain from Nucala Trial Breakthrough?

What’s Behind Genus’s Twenty-Seven Percent Surge in the FTSE 250?
April 30, 2025 06:30 PM BST | By Team Kalkine MediaWhat’s Behind Genus’s Twenty-Seven Percent Surge in the FTSE 250?

How Did GSK and Defensive Names Boost the FTSE 100 Amid US Data Shoc...
April 30, 2025 04:44 PM BST | By Team Kalkine MediaHow Did GSK and Defensive Names Boost the FTSE 100 Amid US Data Shock?

How Did Smith & Nephew Lead Today’s Market Advance?
April 30, 2025 02:24 PM BST | By Team Kalkine MediaHow Did Smith & Nephew Lead Today’s Market Advance?

How Did GSK’s Specialty Medicines Fuel Its Profit Growth?
April 30, 2025 02:16 PM BST | By Team Kalkine MediaHow Did GSK’s Specialty Medicines Fuel Its Profit Growth?

Could Cizzle’s CIZ1B Deal Transform Lung Cancer Screening?
April 28, 2025 10:30 AM BST | By Team Kalkine MediaCould Cizzle’s CIZ1B Deal Transform Lung Cancer Screening?

Could NHS Reforms Reshape Clinical Infrastructure Contracts?
April 28, 2025 09:30 AM BST | By Team Kalkine MediaCould NHS Reforms Reshape Clinical Infrastructure Contracts?

Can ANGLE’s Blood Test Transform HER2 Detection?
April 28, 2025 08:31 AM BST | By Team Kalkine MediaCan ANGLE’s Blood Test Transform HER2 Detection?

Can Arecor’s AT278 and Arestat Platforms Transform Diabetes Care?
April 28, 2025 08:31 AM BST | By Team Kalkine MediaCan Arecor’s AT278 and Arestat Platforms Transform Diabetes Care?

Is GSK’s Vaccine Franchise Under Pressure from U.S. Policy?
April 25, 2025 03:30 PM BST | By Team Kalkine MediaIs GSK’s Vaccine Franchise Under Pressure from U.S. Policy?

Could ACCRUFeR Transform Iron Deficiency Treatment in Japan?
April 22, 2025 02:31 PM BST | By Team Kalkine MediaCould ACCRUFeR Transform Iron Deficiency Treatment in Japan?

Could Savolitinib Trial Enrollment Spark Stock Momentum?
April 22, 2025 01:30 PM BST | By Team Kalkine MediaCould Savolitinib Trial Enrollment Spark Stock Momentum?

Could Arecor’s Ultra‑Concentrated Insulin Revolutionize Diabetes Car...
April 22, 2025 12:30 PM BST | By Team Kalkine MediaCould Arecor’s Ultra‑Concentrated Insulin Revolutionize Diabetes Care?

Could Savolitinib’s Mid‑Stage Milestone Shift Oncology Prospects?
April 22, 2025 11:30 AM BST | By Team Kalkine MediaCould Savolitinib’s Mid‑Stage Milestone Shift Oncology Prospects?
AI on the Rise: A Look at Top AI Companies and Their Stocks